Novo Nordisk Sees Retail Buying Despite Wall Street Cuts

Mitrade
Updated
coverImg
Source: DepositPhotos

Insights – Shares of leading weight-loss drugmaker Novo Nordisk plunged after disappointing results from its latest weight-loss drug trial. Despite analysts slashing their price targets, retail investors flooded into the stock with massive buy-the-dip activity.  


According to data from Vanda Research, retail inflows into Novo Nordisk surged 32-fold on Friday, December 20. The single-day net inflow jumped from $490,000 the previous day to $15.6 million.  


Marco Iachini, Senior Vice President at Vanda Research, noted that retail investors tend to buy the dip, particularly in popular stocks, and added that they would continue doing so until the strategy ceased to be effective.


Novo Nordisk’s December 20 trial results revealed that its next-generation weight-loss drug, CagriSema, achieved only a 22.7% weight loss effect after eight weeks of treatment, falling short of the market expectation of 25%.  


The company’s previous flagship weight-loss drug, Wegovy, had set high standards, and Novo Nordisk had hoped CagriSema would outperform its main competitor, Eli Lilly’s (LLY.US) Zepbound. However, the underwhelming trial results sent Novo Nordisk shares tumbling 17.83% on the day, while Eli Lilly’s stock ended a multi-day decline, rising 1.35%.  


Following the trial results, Wall Street analysts sharply lowered their price targets for Novo Nordisk.BMO Capital** cut its target from $156 to $105.  TD Cowen** reduced its target from $155 to $105.  Jefferies downgraded its target to $81.50 and maintained a "Sell" rating.  


As of the latest close, Novo Nordisk shares traded at $87.37, representing a year-to-date decline of 15.54%.  




* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
Asian stocks climbed following record highs with gains led by Taiwan and AustraliaOn Friday, Asian stocks rose after U.S. markets hit new highs, supported by positive economic data and mixed corporate results.
Author  Cryptopolitan
14 hours ago
On Friday, Asian stocks rose after U.S. markets hit new highs, supported by positive economic data and mixed corporate results.
placeholder
Meta continued effort to increase its workforce with AI experts from AppleMeta has brought two important AI experts from Apple after luring away their manager. 
Author  Cryptopolitan
20 hours ago
Meta has brought two important AI experts from Apple after luring away their manager. 
placeholder
Baidu's Stocks Surge in US and Hong Kong as Apollo Go Teams Up with Uber for Global ExpansionChinese search engine giant Baidu announced a multi-year partnership with ride-hailing titan Uber.
Author  TradingKey
Jul 16, Wed
Chinese search engine giant Baidu announced a multi-year partnership with ride-hailing titan Uber.
placeholder
S&P 500 hits a new all time of 6,300 for the first time everThe S&P 500 broke through 6,300 for the first time in history on Tuesday, as rising demand for crypto stocks and tech names sent U.S. markets higher across the board.
Author  Cryptopolitan
Jul 15, Tue
The S&P 500 broke through 6,300 for the first time in history on Tuesday, as rising demand for crypto stocks and tech names sent U.S. markets higher across the board.
placeholder
Coinbase Stock Hits Record High — Market Cap Tops $100 Billion for First TimeOn Monday, July 14, shares of Coinbase (COIN) surged nearly 2%, reaching an intraday high of $398.50, marking a new all-time high.
Author  TradingKey
Jul 15, Tue
On Monday, July 14, shares of Coinbase (COIN) surged nearly 2%, reaching an intraday high of $398.50, marking a new all-time high.